Ibaraki, Japan

Hiroshi Inooka

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1999-2003.

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Tsukuba, JP (1999 - 2002)
  • Ibaraki, JP (2003)

Company Filing History:


Years Active: 1999-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiroshi Inooka: Innovator in Cyclopentapeptide Research

Introduction

Hiroshi Inooka is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of cyclopentapeptides. With a total of 3 patents, Inooka's work focuses on the design of compounds with biological activity.

Latest Patents

Inooka's latest patents include a groundbreaking invention titled "Pentapeptide with specific conformation, its production and use." This patent discloses cyclic pentapeptides characterized by the formula (I)-Cyclo(-A -A -A -A -A -), where A represents various amino acid residues. The pentapeptide is designed to form a γ-turn with amino acid residues in positions 1-2-3 and a β-turn with residues in positions 3-4-5-1. The invention allows for the synthesis of compounds with desired amino acid residues at specific sites, enhancing their biological activity.

Career Highlights

Hiroshi Inooka is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has been instrumental in advancing research in peptide chemistry and its applications in medicine.

Collaborations

Inooka has collaborated with notable colleagues, including Mitsuhiro Wakimasu and Satoshi Endo. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Hiroshi Inooka's contributions to the field of cyclopentapeptides exemplify the importance of innovation in biochemistry. His patents reflect a commitment to advancing scientific knowledge and developing compounds with significant biological potential.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…